Pediatric Drug Development Market Pediatric drug development Market | Page 2

- Current landscape
- Regulation and legislation
- Global harmonization
- Strategic considerations for developing pediatric medicines
- Clinical trial considerations
- Pediatric formulation issues
- Pediatric networks
- Patient access
- Commercial opportunities
- Generic formulations and dosage forms
- Rare and neglected diseases
- Pediatric vaccines
To Get Full Report Click Here @ http://www.radiantinsights.com/research/pediatric-drugdevelopment-regulatory-challenges-and-commercial-opportunities
Key Reasons to Purchase
- Reviews the current regulatory landscape and helps sponsors to understand the potential impact of FDA
SIA regulations and the variations between EU regulation on global pediatric plans;
- Identifies the key challenges associated with pediatric drug development and the ways to overcome
these hurdles;
- Assesses what issues need to be addressed in order to improve access to pediatric medicines and
commercial opportunities in transition countries based on KOL insights;
- Analyses different strategies to develop age-appropriate medicines in niche therapeutic fields in
neonates, rare and neglected pediatric diseases and pediatric vaccines.
Table of Contents
Executive Summary
How commercially attractive is pediatric drug development?
Why should pharma invest in pediatric medicines?